Teladoc Health, Inc. (NYSE: TDOC) Receives Average “Hold” Recommendation from Brokerages

0

Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received a consensus rating of “Hold” from the thirty-three ratings companies that cover the stock, MarketBeat.com reports. One investment analyst gave the stock a sell rating, nineteen issued a hold rating and five issued a buy rating for the company. The 12-month average price target among brokerages that have reported on the stock over the past year is $62.28.

A number of brokerages have weighed in on TDOC. Wells Fargo & Company cut Teladoc Health shares from an “overweight” rating to a “weighted” rating and lowered its target price for the stock from $104.00 to $40.00 in a Thursday 28 report. april. JPMorgan Chase & Co. cut Teladoc Health shares from an “overweight” rating to a “neutral” rating in a Thursday, April 28 report. Piper Sandler lowered its price target on Teladoc Health shares from $42.00 to $40.00 and set an “overweight” rating on the stock in a Thursday, July 28 report. Needham & Company LLC cut shares of Teladoc Health from a “buy” rating to a “hold” rating in a Thursday, July 28, report. Finally, Deutsche Bank Aktiengesellschaft lowered its price target on Teladoc Health shares from $44.00 to $34.00 in a Friday, July 29 report.

Insider buying and selling

A d Tradewins

The safest option in the trades!

If you’re new to trading, you’ve probably heard the wrong word about options, that they’re risky, unpredictable, or difficult. And it couldn’t be more wrong! With the Hughes Optioneering strategy, you will soon learn that the safest option for new accounts is the options themselves!

In addition, SVP Daniel Trencher sold 1,000 shares of the company in a transaction that took place on Friday, June 17. The stock was sold at an average price of $29.12, for a total transaction of $29,120.00. Following the sale, the senior vice president now owns 28,408 shares of the company, valued at $827,240.96. The sale was disclosed in a filing with the SEC, which is available on the SEC’s website. In other Teladoc Health news, Chief Financial Officer Mala Murthy sold 4,053 shares of the company in a trade on Monday, June 27. The stock was sold at an average price of $37.32, for a total value of $151,257.96. Following the transaction, the CFO now owns 27,295 shares of the company, valued at $1,018,649.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available via this link. Additionally, SVP Daniel Trencher sold 1,000 shares of the company in a trade on Friday, June 17. The shares were sold at an average price of $29.12, for a total value of $29,120.00. Following completion of the transaction, the Senior Vice President now directly owns 28,408 shares of the company, valued at approximately $827,240.96. The disclosure of this sale can be found here. Insiders sold a total of 6,053 shares of the company valued at $221,498 during the last quarter. Company insiders own 1.55% of the company’s shares.

Institutional entries and exits

Several institutional investors have recently changed their stock portfolios. ARK Investment Management LLC increased its holdings of Teladoc Health shares by 2.9% in the first quarter. ARK Investment Management LLC now owns 19,466,931 shares of the healthcare provider valued at $1,404,150,000 after buying an additional 544,733 shares last quarter. Vanguard Group Inc. increased its holdings of Teladoc Health shares by 0.7% in the first quarter. Vanguard Group Inc. now owns 13,238,243 shares of the healthcare provider valued at $954,875,000 after buying an additional 98,181 shares last quarter. Nikko Asset Management Americas Inc. increased its holdings of Teladoc Health shares by 18.2% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 8,755,058 shares of the healthcare provider valued at $809,843,000 after buying an additional 1,349,776 shares last quarter. Kinnevik AB publ bought a new position in shares of Teladoc Health in the fourth quarter worth $458,235,000. Finally, State of Michigan Retirement System acquired a new stake in Teladoc Health during the 2nd quarter at a value of $123,089,000. Institutional investors hold 87.17% of the company’s shares.

Teladoc Health trades up 6.7%

TDOC opened at $37.79 on Thursday. The stock has a market capitalization of $6.09 billion, a PE ratio of -0.62 and a beta of 0.82. The company’s fifty-day moving average price is $36.66 and its 200-day moving average price is $51.10. The company has a debt ratio of 0.25, a current ratio of 3.38 and a quick ratio of 3.22. Teladoc Health has a 12 month minimum of $27.38 and a 12 month maximum of $156.82.

About Teladoc Health

(Get an evaluation)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering elective, episodic, chronic and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure and mental health issues. .

Further reading

Analyst Recommendations for Teladoc Health (NYSE: TDOC)

This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider Teladoc Health, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and Teladoc Health wasn’t on the list.

While Teladoc Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

Share.

Comments are closed.